Experimental Study on Therapeutic Effects of Antisense Oligonucleotides of Telomerase on BIU87 Cell of Bladder Cancer in Vitro

许宁,石爱平,姜艳芳,王春喜,王有德,赵忠文

DOI: https://doi.org/10.3969/j.issn.1671-587x.2004.01.015

2004-01-01

Abstract:Objective To investigate the therapy effects of the antisense oligonucleotides of telomerase on the BIU87 cell derived from bladder cancer. Methods Telomerase activities in 25 tissue specimens of bladder cancer and 4 normal ones were detected by TRAP AgNO 3 stain.The phosphorothioate antisense oligonucleotides (PS ASON) of differential doses with sequence TTAGGGTTAGACAA targeted to telomerase RNA template (as experiment group A,B, and C), PS random primer with 13 nucleotides (as control group,D),and culture medium only (as empty control group,E) were incubated with the BIU87 cell lines. The number of cells were counted from 1 to 30 days, The apoptotic rate was assayed by flow cytometry. Apoptosis was detected by DNA ladder electrophoresis. The cell form was observed with light and electron microscope. Results Of 25 cases of bladder cancer, the activities of telomerases were expressed in 24 cases (96%), there was no expression in 4 normal tissues. ASON in experiment group reduced the number of cells compared with group D and E. The transparent apoptotic cusp at flow cytometry and revealed ladder electrophsis zone were presented in experiment groups at 2nd, 8th day and 8 days later. Degeneration, aging, necrosis, and apoptosis occurred under the microscope. The efficacy depended on the doses of ASON ( P 0 01) and it was of sequence selective specifity. Conclusion Inhibition of BIU87 cell proliferation, aging,necrosis,and apoptosis induced by ASON targeted hTR may have potential significance in tumor therapy.